Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of oral ferrous sulfate on urinary hepcidin excretion in patients with hemochromatosis
2005-000170-40Phase 2Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ferrous sulfate in hemochromatosis (HH), sponsored by IRCCS Ospedale San Raffaele. Primary endpoint: Urinary hepcidin excretion after oral ferrous sulfate. Started Jul 2005; status: completed.
02
Drugs
ferrous sulfate
03
Conditions
hemochromatosis (HH)
Beyond the preview
Go deeper on 2005-000170-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000170-40.